The TrimRx Approach to Personalized Care We believe that medical weight loss is not a one-size-fits-all journey
Frias JP, Bastyr EJ 3rd, Vignati L et al (2017) The sustained effects of a dual GIP/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes
Preclinical research indicates GHK-Cu has the capacity to modulate the expression of over 4,000 human genes, according to bioinformatics analyses conducted by Pickart and colleagues, with a substantial subset of these genes tied directly to extracellular matrix maintenance, collagen production, and tissue-repair signaling
Metformin is FDA-approved for type 2 diabetes and is sometimes prescribed off-label as part of weight management approaches
Discuss all medications you are taking, as semaglutide may interact with other drugs
At HormoneSynergy Clinic, we use medication thoughtfully when it is appropriate